Safety of Oral Resin for Treatment of Hyperkalemia in Chinese Patients With Renal Insufficiency

Pharmacokinetic and Pharmacodynamic Profiles of Aliskiren in Japanese Patients With Mild to Moderate Essential Hypertension

NCT00424541 ·Status: COMPLETED ·Phase: PHASE1

Double-dose Valsartan Monotherapy in Hypertension Treatment: an Effectiveness and Safety Evaluation in Chinese Patients.

NCT01541189 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Mexartan Potassium Tablets (AZL-M) and Calcium Channel Blockers (CCB) in the Treatment of Adults With Essential Hypertension in Chinese Population: a National Multicenter, Prospective, Observational Study

NCT05947448 ·Status: RECRUITING

To Evaluate the Efficacy and Safety of KN060 in Essential Hypertension

NCT07191899 ·Status: RECRUITING ·Phase: PHASE1

Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD

NCT01617681 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Study to Compare the Safety and Pharmacokinetics of CKD-320 and D012

NCT04035538 ·Status: UNKNOWN ·Phase: PHASE1

Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D956 in Healthy Adults

NCT06281132 ·Status: COMPLETED ·Phase: PHASE1

Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-341 in Healthy Subjects

NCT05571813 ·Status: COMPLETED ·Phase: PHASE1

Sacubitril/Valsartan for CKD5 Stage Dialysis Patients

NCT05243199 ·Status: COMPLETED ·Phase: PHASE4

Effects and Safety of Sacubitril/Valsartan on Refractory Hypertension

NCT05545059 ·Status: UNKNOWN ·Phase: PHASE3

Trial on the Safety and Efficacy of MLS-101 in Patients With Uncontrolled Hypertension

NCT05001945 ·Status: COMPLETED ·Phase: PHASE2

To Assess Allisartan Isoproxil/Sustained-Release Indapamide in Patients With Essential Hypertension Uncontrolled With Allisartan Isoproxil

NCT06500689 ·Status: COMPLETED ·Phase: PHASE3

Azilsartan Medoxomil (TAK-491) Compared to Valsartan in Chinese Participants With Hypertension

NCT02480764 ·Status: COMPLETED ·Phase: PHASE3

A Phase 2 Exploratory Study of CS-3150 in Japanese Hypertensive Patients With Moderate Renal Impairment

NCT02448628 ·Status: COMPLETED ·Phase: PHASE2

Endothelin-1 Receptor Blockade in Resistant Hypertension

NCT04388124 ·Status: RECRUITING ·Phase: PHASE2

Atacand Dose Ranging in Hypertensive Pediatric Subjects 1 Year to Less Than 6 Years of Age

NCT00244621 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Aliskiren 75 mg, 150 mg, and 300 mg in Elderly Patients With Essential Hypertension When Given With a Light Meal in a 8 Week Placebo-controlled Study

NCT00706134 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety/Tolerability and Pharmacokinetics of Aliskiren in Hypertensive Pediatric and Adolescent Patients 6-17 Years of Age

NCT00834041 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Nighttime Valsartan in Hemodialysis Hypertension

NCT03594825 ·Status: UNKNOWN ·Phase: PHASE4

A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions

NCT06193187 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Efficacy and Safety of Azilsartan Medoxomil in African American Participants With Essential Hypertension

NCT00591253 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Azilsartan Medoxomil Co-Administered With Chlorthalidone in Participants With Essential Hypertension

NCT00591773 ·Status: COMPLETED ·Phase: PHASE3

Hemodynamic Effects of Aliskiren Compared to Captopril on the Kidney in Healthy Volunteers on a Low- and High- Sodium Diet

NCT00518765 ·Status: COMPLETED ·Phase: PHASE3

A Phase 3 Pharmacokinetic Study of TAK-536 (Azilsartan) in Pediatric Patients 6 to Less Than 16 Years With Hypertension

NCT02451150 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Hypertensive Subjects

NCT02345044 ·Status: COMPLETED ·Phase: PHASE2